| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0002027 | Regulation of heart rate | Increases phenotype | PMID:16432681 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:29753867 |
| GO:0005975 | Carbohydrate metabolic process | Affects phenotype | PMID:39098565 |
| GO:0006537 | Glutamate biosynthetic process | Increases phenotype | PMID:29753867 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:34266355 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:29753867 |
| GO:0006805 | Xenobiotic metabolic process | Affects phenotype | PMID:25745819 |
| GO:0006811 | Monoatomic ion transport | Affects phenotype | PMID:12972176; PMID:15128855 |
| GO:0006979 | Response to oxidative stress | Decreases phenotype | PMID:18949505 |
| GO:0007610 | Behavior | Affects phenotype | PMID:22489711 |
| GO:0007635 | Chemosensory behavior | Increases phenotype | PMID:34266355 |
| GO:0008217 | Regulation of blood pressure | Decreases phenotype | PMID:17363756; PMID:17391164 |
| GO:0008219 | Cell death | Increases phenotype | PMID:15128855; PMID:17636003 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:15591643 |
| GO:0008344 | Adult locomotory behavior | Decreases phenotype | PMID:29753867 |
| GO:0009449 | Gamma-aminobutyric acid biosynthetic process | Decreases phenotype | PMID:29753867 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:29753867 |
| GO:0019722 | Calcium-mediated signaling | Increases phenotype | PMID:15128855 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:34266355 |
| GO:0035641 | Locomotory exploration behavior | Decreases phenotype | PMID:29753867 |
| GO:0042311 | Vasodilation | Affects phenotype | PMID:15980877 |
| GO:0042416 | Dopamine biosynthetic process | Decreases phenotype | PMID:29753867 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:15591643; PMID:18949505 |
| GO:0051970 | Negative regulation of transmission of nerve impulse | Increases phenotype | PMID:19417176 |
| GO:0060079 | Excitatory postsynaptic potential | Decreases phenotype | PMID:12972176 |
| GO:0060080 | Inhibitory postsynaptic potential | Affects phenotype | PMID:19417176 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:29753867; PMID:34266355 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:34266355 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.